These variants were selected based on their annotation as eQTLs or somatic variants in breast cancer, their proximity to putative target genes, predicted regulatory impact based on the GEMSTAT ensemble as well as experimental TF binding data supporting the model-suggested mechanism. This evidence concerns the gene TF and breast carcinoma.